Literature DB >> 19369450

Gonadotropin-releasing hormone-regulated chemokine expression in human placentation.

P Craig Cavanagh1, Caroline Dunk, Macarena Pampillo, Jacob M Szereszewski, Jay E Taylor, Caroline Kahiri, Victor Han, Stephen Lye, Moshmi Bhattacharya, Andy V Babwah.   

Abstract

Placental expression of gonadotropin-releasing hormone (GnRH)-I and II, as well as their cognate receptor, coincides with a period of extensive remodeling of the maternal-fetal interface, near the end of the first trimester of pregnancy. To further define the role of GnRH in human placentation, we performed a microarray screen of HTR-8/SVneo trophoblasts to identify GnRH-regulated genes and their roles in placentation. This screen revealed that GnRH regulates the expression of four angiogenic chemokines: CXCL2, CXCL3, CXCL6, and CXCL8. The microarray data were subsequently confirmed by an extensive Q-PCR time-course analysis. CXCL8, a representative chemokine, was selected for further analysis and shown to be strongly expressed by trophoblasts at the maternal-fetal interface of the human placenta, as well as to accumulate in a GnRH-dependent manner in trophoblast-conditioned media in culture. Trophoblasts were subsequently shown to recruit lymphocytes (Jurkat T cells and primary peripheral blood T and uterine natural killer cells) in chemotaxis assays and this was shown to be GnRH dependent. Furthermore, this recruitment was shown to occur via the release of CXCR1/CXCR2 interacting chemokines, such as the CXCLs investigated in this study. This novel regulation of chemokines by GnRH signaling demonstrates the role of GnRH in regulating the recruitment of lymphocytes to the decidua and the possibility of a direct effect on spiral artery remodeling via the release of proangiogenic chemokines and secondary effects via release of angiogenic factors by recruited lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369450     DOI: 10.1152/ajpcell.00013.2009

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  11 in total

1.  Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro.

Authors:  Aleah D Hazan; Samantha D Smith; Rebecca L Jones; Wendy Whittle; Stephen J Lye; Caroline E Dunk
Journal:  Am J Pathol       Date:  2010-06-17       Impact factor: 4.307

Review 2.  Fetomaternal immune cross-talk and its consequences for maternal and offspring's health.

Authors:  Petra C Arck; Kurt Hecher
Journal:  Nat Med       Date:  2013-05-07       Impact factor: 53.440

3.  The human gonadotropin releasing hormone type I receptor is a functional intracellular GPCR expressed on the nuclear membrane.

Authors:  Michelle Re; Macarena Pampillo; Martin Savard; Céléna Dubuc; Craig A McArdle; Robert P Millar; P Michael Conn; Fernand Gobeil; Moshmi Bhattacharya; Andy V Babwah
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

4.  Regulation of GPR54 signaling by GRK2 and {beta}-arrestin.

Authors:  Macarena Pampillo; Natasha Camuso; Jay E Taylor; Jacob M Szereszewski; Maryse R Ahow; Mateusz Zajac; Robert P Millar; Moshmi Bhattacharya; Andy V Babwah
Journal:  Mol Endocrinol       Date:  2009-10-21

Review 5.  Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients.

Authors:  Sakthivel Muniyan; Lei Xi; Kaustubh Datta; Anindita Das; Benjamin A Teply; Surinder K Batra; Rakesh C Kukreja
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-06-11       Impact factor: 10.680

6.  Conditional loss of ERK1 and ERK2 results in abnormal placentation and delayed parturition in the mouse.

Authors:  Jessica L Brown; Jennifer L Sones; Cynthia N Angulo; Keelin Abbott; Andrew D Miller; Ulrich Boehm; Mark S Roberson
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

7.  Polymorphisms in inflammation pathway genes and endometrial cancer risk.

Authors:  Ryan J Delahanty; Yong-Bing Xiang; Amanda Spurdle; Alicia Beeghly-Fadiel; Jirong Long; Deborah Thompson; Ian Tomlinson; Herbert Yu; Diether Lambrechts; Thilo Dörk; Marc T Goodman; Ying Zheng; Helga B Salvesen; Ping-Ping Bao; Frederic Amant; Matthias W Beckmann; Lieve Coenegrachts; An Coosemans; Natalia Dubrowinskaja; Alison Dunning; Ingo B Runnebaum; Douglas Easton; Arif B Ekici; Peter A Fasching; Mari K Halle; Alexander Hein; Kimberly Howarth; Maggie Gorman; Dylyara Kaydarova; Camilla Krakstad; Felicity Lose; Lingeng Lu; Galina Lurie; Tracy O'Mara; Rayna K Matsuno; Paul Pharoah; Harvey Risch; Madeleine Corssen; Jone Trovik; Nurzhan Turmanov; Wanqing Wen; Wei Lu; Qiuyin Cai; Wei Zheng; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-05       Impact factor: 4.254

8.  Hypothalamic neurohormones and immune responses.

Authors:  J Luis Quintanar; Irene Guzmán-Soto
Journal:  Front Integr Neurosci       Date:  2013-08-13

9.  Inconformity of CXCL3 plasma level and placenta expression in preeclampsia and its effect on trophoblast viability and invasion.

Authors:  Shunping Gui; Shanshan Ni; Jin Jia; Yunhui Gong; Linbo Gao; Lin Zhang; Rong Zhou
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

10.  Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(-/-) mice.

Authors:  Anki Knutsson; Sabrina Hsiung; Selvi Celik; Sara Rattik; Ingrid Yao Mattisson; Maria Wigren; Howard I Scher; Jan Nilsson; Anna Hultgårdh-Nilsson
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.